Biodiversity talks in final days with many issues unresolved

Negotiators at a United Nations biodiversity conference Saturday have still not resolved most of the key issues around protecting the world's nature by 2030 and providing tens of billions of dollars to developing countries to fund those efforts.

source https://www.lifetechnology.com/blogs/life-technology-science-news/biodiversity-talks-in-final-days-with-many-issues-unresolved

Arctic Report Card reveals rainier, shifting seasons with broad disturbances

In the Arctic, the freedom to travel, hunt and make day-to-day decisions is profoundly tied to cold and frozen conditions for much of the year. These conditions are rapidly changing as the Arctic warms.

source https://www.lifetechnology.com/blogs/life-technology-science-news/arctic-report-card-reveals-rainier-shifting-seasons-with-broad-disturbances

Short bursts of physical activity during daily life may lower risk of premature death

Most of us know that regular exercise is important for our health and longevity. But with our busy schedules, many of us struggle to find the time to fit in a workout. Data from our latest study has shown that you don't need a lengthy workout to get health benefits from exercise.

Malaysia landslide death toll rises to 23

Rescue workers scoured muddy terrain for survivors and bodies on Saturday as the death toll from a landslide at a Malaysian campsite rose to 23, including six children, authorities said.

source https://www.lifetechnology.com/blogs/life-technology-science-news/malaysia-landslide-death-toll-rises-to-23

Twitter chaos too much? There are plenty of other options

Twitter has been engulfed in chaos since billionaire Tesla CEO Elon Musk took the helm, cutting the company's workforce in half, upending the platform's verification system, reinstating previously banned accounts—including those of white nationalists—and suspending journalists who've been covering him.

source https://www.lifetechnology.com/blogs/life-technology-technology-news/twitter-chaos-too-much-there-are-plenty-of-other-options

FDA approves "glowing tumor" imaging drug to aid lung cancer surgery

The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds to cancerous tissue and glows when stimulated by near-infrared light, making it easier for surgeons to remove tumors completely while sparing healthy tissue.